Emplois de private equity analyst – Louvain

Compensation: EUR 41,100 - EUR 43,500 - yearlyJob DescriptionOur Media Measurement department delivers robust and independent metrics on audio and video. Our core business is helping media companies by providing them with the right data for audience analysis. We received continuous data from surveys that help our customers to define trends and strategies.We...

Mission As a Business Intelligence Analyst within our Proton Therapy Business Unit, you will help turn business data into meaningful insights that support smarter, faster decision-making. Working across the different departments of the Proton Therapy organization, you will act as a key link between business stakeholders and data engineers. You will...

Mission As a Business Intelligence Analyst within our Proton Therapy Business Unit, you will help turn business data into meaningful insights that support smarter, faster decision-making. Working across the different departments of the Proton Therapy organization, you will act as a key link between business stakeholders and data engineers. You will...

Select how often (in days) to receive an alert: Share this job offer on IS Business Analyst SAP Requisition ID: 4671 Location: Louvain-la-Neuve, BE Work regime: Full-Time Kind of contract: Fixed Term Contract Mission IBA develops proton therapy solutions and particle accelerator technologies that help diagnose and treat cancer. Following our migration from...

Mission IBA develops proton therapy solutions and particle accelerator technologies that help diagnose and treat cancer. Following our migration from SAP ECC to SAP S/4HANA, you will help shape logistics and supply chain processes in a global company. Your mission You will stabilize, optimize and develop our SAP S/4HANA logistics landscape. Working with...

Introduction IBA Radiopharma Solutions develops innovative technologies and integrated solutions supporting the production of radiopharmaceuticals used in diagnosis and targeted therapies. Serving hospitals, radiopharmacies, nuclear medicine departments, research centers, and industrial partners worldwide, we contribute to expanding access to...